Market Exclusive

Analyst Activity – Oppenheimer Reiterates Buy on TherapeuticsMD (NASDAQ:TXMD)

Analyst Ratings For TherapeuticsMD (NASDAQ:TXMD)

Today, Oppenheimer reiterated its Buy rating on TherapeuticsMD (NASDAQ:TXMD).

Some recent analyst ratings include

Recent Insider Trading Activity For TherapeuticsMD (NASDAQ:TXMD)
TherapeuticsMD (NASDAQ:TXMD) has insider ownership of 23.92% and institutional ownership of 73.27%.

Recent Trading Activity for TherapeuticsMD (NASDAQ:TXMD)
Shares of TherapeuticsMD closed the previous trading session at 5.16 up +0.07 1.27% with 5.070000171661377 shares trading hands.

Exit mobile version